title: Criminalizing knowledge: the perverse implications of the intended use regulations of off-label promotion prosecutions.
abstract: Your company has spent months designing a compliance program and training your sales representatives. They know never to mention the off-label uses of your product. If they are asked about the off-label uses by the physician they are detailing, they know to forward those inquiries to the scientific liaisons at headquarters. But, could your company still be in legal jeopardy simply because it knows that the product is being used for an off-label purpose? This article attempts to track the Food and Drug Administration's (FDA's) shifting interpretation of its "intended use" regulations, from focusing entirely on the statements of the manufacturers to focusing on the knowledge of the industry, indeed, of the consumers of products, in determining the true intended use of a product. It will look at several recent attempts by FDA to use that new interpretation of the regulations to expand its power: to regulate tobacco and to require pediatric indications for any new drug. Finally, it will look at several recent examples of how this new interpretation has manifested in actions by FDA and the Department of Justice (DOJ).
authors.affiliation: Morrison Mahoney, LLP, Boston, Massachusetts, USA.
authors.forename: Gregory
authors.initials: G
authors.lastname: Gentry
mesh_terms: D003415:Crime / Q000331:legislation & jurisprudence* / Q000517:prevention & control; D018795:Device Approval / Q000331:legislation & jurisprudence*; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D004348:Drug Labeling / Q000331:legislation & jurisprudence*; D005607:Fraud / Q000331:legislation & jurisprudence / Q000517:prevention & control; D033161:Government Regulation; D007722:Health Knowledge, Attitudes, Practice; D049673:History, 20th Century; D006801:Humans; D033182:Intention; D017387:Investigational New Drug Application / Q000331:legislation & jurisprudence; D016365:Liability, Legal; D008389:Marketing of Health Services / Q000331:legislation & jurisprudence*; D056687:Off-Label Use / Q000266:history / Q000331:legislation & jurisprudence*; D010818:Practice Patterns, Physicians' / Q000331:legislation & jurisprudence; D019460:Tobacco Industry / Q000331:legislation & jurisprudence; D014481:United States; D014486:United States Food and Drug Administration